{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:57:06Z","timestamp":1762300626066,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007691","name":"Universidade da Beira Interior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is the second most prevalent neurodegenerative disease and the most common movement disorder. Although PD etiology is not fully understood, alpha (\u03b1)-synuclein is a key protein involved in PD pathology. MicroRNAs (miRNA), small gene regulatory RNAs that control gene expression, have been identified as biomarkers and potential therapeutic targets for brain diseases, including PD. In particular, miR-124 is downregulated in the plasma and brain samples of PD patients. Recently we showed that the brain delivery of miR-124 counteracts 6-hydroxydopamine-induced motor deficits. However, its role in \u03b1-synuclein pathology has never been addressed. Here we used paraquat (PQ)-induced rat PD model to evaluate the role of miR-124-3p in \u03b1-synuclein accumulation and dopaminergic neuroprotection. Our results showed that an intranigral administration of miR-124-3p reduced the expression and aggregation of \u03b1-synuclein in the <jats:italic>substantia nigra<\/jats:italic> (SN) of rats exposed to PQ. NADPH oxidases (NOX), responsible for reactive oxygen species generation, have been considered major players in the development of \u03b1-synuclein pathology. Accordingly, miR-124-3p decreased protein expression levels of NOX1 and its activator, small GTPase Rac1, in the SN of PQ-lesioned rats. Moreover, miR-124-3p was able to counteract the reduced levels of pituitary homeobox 3 (PITX3), a protein required for the dopaminergic phenotype, induced by PQ in the SN. This is the first study showing that miR-124-3p decreases PQ-induced \u03b1-synuclein levels and the associated NOX1\/Rac1 signaling pathway, and impacts PITX3 protein levels, supporting the potential of miR-124-3p as a disease-modifying agent for PD and related \u03b1-synucleinopathies.<\/jats:p>","DOI":"10.1007\/s11064-024-04130-y","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T06:01:52Z","timestamp":1709791312000},"page":"1677-1686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"49","author":[{"given":"Marta","family":"Esteves","sequence":"first","affiliation":[]},{"given":"Ana Clara","family":"Crist\u00f3v\u00e3o","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Vale","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Machado-Pereira","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Ferreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3395-5973","authenticated-orcid":false,"given":"Liliana","family":"Bernardino","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"4130_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4130_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/SCIENCE.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J et al (2012) Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953. https:\/\/doi.org\/10.1126\/SCIENCE.1227157","journal-title":"Science"},{"key":"4130_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP et al (2011) Exogenous \u03b1-Synuclein fibrils induce Lewy Body Pathology leading to synaptic dysfunction and Neuron Death. Neuron 72:57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"key":"4130_CR4","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/JBC.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM et al (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739\u201329752. https:\/\/doi.org\/10.1074\/JBC.M600933200","journal-title":"J Biol Chem"},{"key":"4130_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/J.MCN.2018.04.009","volume":"91","author":"B Bingol","year":"2018","unstructured":"Bingol B (2018) Autophagy and lysosomal pathways in nervous system disorders. Mol Cell Neurosci 91:167\u2013208. https:\/\/doi.org\/10.1016\/J.MCN.2018.04.009","journal-title":"Mol Cell Neurosci"},{"key":"4130_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/J.NBD.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257. https:\/\/doi.org\/10.1016\/J.NBD.2017.04.004","journal-title":"Neurobiol Dis"},{"key":"4130_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bcp.2017.07.008","volume":"141","author":"C Saraiva","year":"2017","unstructured":"Saraiva C, Esteves M, Bernardino L (2017) MicroRNA: basic concepts and implications for regeneration and repair of neurodegenerative diseases. Biochem Pharmacol 141:118\u2013131. https:\/\/doi.org\/10.1016\/j.bcp.2017.07.008","journal-title":"Biochem Pharmacol"},{"key":"4130_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuroscience.2014.04.039","volume":"272","author":"N Kanagaraj","year":"2014","unstructured":"Kanagaraj N, Beiping H, Dheen ST, Tay SSW (2014) Downregulation of miR-124 in MPTP-treated mouse model of Parkinson\u2019s disease and MPP iodide-treated MN9D cells modulates the expression of the calpain\/cdk5 pathway proteins. Neuroscience 272:167\u2013179. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.04.039","journal-title":"Neuroscience"},{"key":"4130_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10072-017-2841-9","volume":"38","author":"N Li","year":"2017","unstructured":"Li N, Pan X, Zhang J et al (2017) Plasma levels of miR-137 and miR-124 are associated with Parkinson\u2019s disease but not with Parkinson\u2019s disease with depression. Neurol Sci 38:761\u2013767. https:\/\/doi.org\/10.1007\/s10072-017-2841-9","journal-title":"Neurol Sci"},{"key":"4130_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.brainres.2010.03.106","volume":"1338","author":"K-C Sonntag","year":"2010","unstructured":"Sonntag K-C (2010) MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res 1338:48\u201357. https:\/\/doi.org\/10.1016\/j.brainres.2010.03.106","journal-title":"Brain Res"},{"key":"4130_CR11","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1096\/fj.201900363R","volume":"33","author":"L Yao","year":"2019","unstructured":"Yao L, Zhu Z, Wu J et al (2019) MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease. FASEB J 33:8648\u20138665. https:\/\/doi.org\/10.1096\/fj.201900363R","journal-title":"FASEB J"},{"key":"4130_CR12","first-page":"2127","volume":"8","author":"X Gong","year":"2016","unstructured":"Gong X, Wang H, Ye Y et al (2016) miR-124 regulates cell apoptosis and autophagy in dopaminergic neurons and protects them by regulating AMPK\/mTOR pathway in Parkinson\u2019s disease. Am J Transl Res 8:2127\u20132137","journal-title":"Am J Transl Res"},{"key":"4130_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/bpa.12267","volume":"26","author":"H Wang","year":"2016","unstructured":"Wang H, Ye Y, Zhu Z et al (2016) MiR-124 regulates apoptosis and autophagy process in MPTP Model of Parkinson\u2019s disease by targeting to Bim. Brain Pathol 26:167\u2013176. https:\/\/doi.org\/10.1111\/bpa.12267","journal-title":"Brain Pathol"},{"key":"4130_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jcb.26170","volume":"119","author":"RF Dong","year":"2018","unstructured":"Dong RF, Zhang B, Tai LW et al (2018) The neuroprotective role of MiR-124-3p in a 6-Hydroxydopamine-Induced Cell Model of Parkinson\u2019s Disease via the regulation of ANAX5. J Cell Biochem 119:269\u2013277. https:\/\/doi.org\/10.1002\/jcb.26170","journal-title":"J Cell Biochem"},{"key":"4130_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1089\/ars.2011.3960","volume":"16","author":"D-H Choi","year":"2012","unstructured":"Choi D-H, Crist\u00f3v\u00e3o AC, Guhathakurta S et al (2012) NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson\u2019s disease. Antioxid Redox Signal 16:1033\u20131045. https:\/\/doi.org\/10.1089\/ars.2011.3960","journal-title":"Antioxid Redox Signal"},{"key":"4130_CR16","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/JBC.C100560200","volume":"277","author":"AB Manning-Bog","year":"2002","unstructured":"Manning-Bog AB, McCormack AL, Li J et al (2002) The Herbicide Paraquat causes Up-regulation and aggregation of \u03b1-Synuclein in mice: PARAQUAT AND \u03b1-SYNUCLEIN. J Biol Chem 277:1641\u20131644. https:\/\/doi.org\/10.1074\/JBC.C100560200","journal-title":"J Biol Chem"},{"key":"4130_CR17","doi-asserted-by":"publisher","first-page":"14465","DOI":"10.1523\/JNEUROSCI.2246-12.2012","volume":"32","author":"AC Crist\u00f3v\u00e3o","year":"2012","unstructured":"Crist\u00f3v\u00e3o AC, Guhathakurta S, Bok E et al (2012) NADPH oxidase 1 mediates \u03b1-synucleinopathy in Parkinson\u2019s disease. J Neurosci 32:14465\u201314477. https:\/\/doi.org\/10.1523\/JNEUROSCI.2246-12.2012","journal-title":"J Neurosci"},{"key":"4130_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/bs.pbr.2020.02.003","volume":"252","author":"MA Cenci","year":"2020","unstructured":"Cenci MA, Bj\u00f6rklund A (2020) Animal models for preclinical Parkinson\u2019s research: an update and critical appraisal. Prog Brain Res 252:27\u201359. https:\/\/doi.org\/10.1016\/bs.pbr.2020.02.003","journal-title":"Prog Brain Res"},{"key":"4130_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cdd.2009.217","volume":"17","author":"C Berry","year":"2010","unstructured":"Berry C, La Vecchia C, Nicotera P (2010) Paraquat and Parkinson\u2019s disease. Cell Death Differ 17:1115\u20131125. https:\/\/doi.org\/10.1038\/cdd.2009.217","journal-title":"Cell Death Differ"},{"key":"4130_CR20","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1111\/ejn.14683","volume":"52","author":"AC Crist\u00f3v\u00e3o","year":"2020","unstructured":"Crist\u00f3v\u00e3o AC, Campos FL, Je G et al (2020) Characterization of a Parkinson\u2019s disease rat model using an upgraded paraquat exposure paradigm. Eur J Neurosci 52:3242\u20133255. https:\/\/doi.org\/10.1111\/ejn.14683","journal-title":"Eur J Neurosci"},{"key":"4130_CR21","doi-asserted-by":"publisher","first-page":"108831","DOI":"10.1016\/j.neuropharm.2021.108831","volume":"201","author":"MH Ahmad","year":"2021","unstructured":"Ahmad MH, Fatima M, Ali M et al (2021) Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson\u2019s disease. Neuropharmacology 201:108831. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108831","journal-title":"Neuropharmacology"},{"key":"4130_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00726-021-03104-6\/FIGURES\/8","volume":"54","author":"K Wang","year":"2022","unstructured":"Wang K, Zhang B, Tian T et al (2022) Taurine protects dopaminergic neurons in paraquat-induced Parkinson\u2019s disease mouse model through PI3K\/Akt signaling pathways. Amino Acids 54:1\u201311. https:\/\/doi.org\/10.1007\/S00726-021-03104-6\/FIGURES\/8","journal-title":"Amino Acids"},{"key":"4130_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JPD-160779","volume":"6","author":"A Oueslati","year":"2016","unstructured":"Oueslati A (2016) Implication of alpha-synuclein phosphorylation at S129 in Synucleinopathies: what have we learned in the last decade? J Parkinsons Dis 6:39\u201351. https:\/\/doi.org\/10.3233\/JPD-160779","journal-title":"J Parkinsons Dis"},{"key":"4130_CR24","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/S13311-021-01130-6","volume":"18","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhao M, Yan R et al (2021) MicroRNA-7 protects against Neurodegeneration Induced by \u03b1-Synuclein preformed fibrils in the mouse brain. Neurotherapeutics 18:2529\u20132540. https:\/\/doi.org\/10.1007\/S13311-021-01130-6","journal-title":"Neurotherapeutics"},{"key":"4130_CR25","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/J.CELL.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SIA, Deas E et al (2012) Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell 149:1048\u20131059. https:\/\/doi.org\/10.1016\/J.CELL.2012.03.037","journal-title":"Cell"},{"doi-asserted-by":"publisher","unstructured":"Bridi JC, Hirth F (2018) Mechanisms of \u03b1-Synuclein Induced Synaptopathy in Parkinson\u2019s Disease. Front Neurosci 12. https:\/\/doi.org\/10.3389\/fnins.2018.00080","key":"4130_CR26","DOI":"10.3389\/fnins.2018.00080"},{"key":"4130_CR27","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella R, Chen SW, Bigi A et al (2021) The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells. Nat Commun 12:1814. https:\/\/doi.org\/10.1038\/s41467-021-21937-3","journal-title":"Nat Commun"},{"key":"4130_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CELLS10030656","volume":"10","author":"D Koziorowski","year":"2021","unstructured":"Koziorowski D, Figura M, Milanowski \u0141M et al (2021) Mechanisms of neurodegeneration in various forms of parkinsonism\u2014similarities and differences. Cells 10:1\u201329. https:\/\/doi.org\/10.3390\/CELLS10030656","journal-title":"Cells"},{"key":"4130_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-017-0154-3","volume":"12","author":"TE Moors","year":"2017","unstructured":"Moors TE, Hoozemans JJM, Ingrassia A et al (2017) Therapeutic potential of autophagy-enhancing agents in Parkinson\u2019s disease. Mol Neurodegener 12:11. https:\/\/doi.org\/10.1186\/s13024-017-0154-3","journal-title":"Mol Neurodegener"},{"key":"4130_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s12640-022-00490-x","volume":"40","author":"K Wang","year":"2022","unstructured":"Wang K, Zhang B, Zhang B et al (2022) Paraquat inhibits Autophagy Via intensifying the Interaction between HMGB1 and \u03b1-Synuclein. Neurotox Res 40:520\u2013529. https:\/\/doi.org\/10.1007\/s12640-022-00490-x","journal-title":"Neurotox Res"},{"key":"4130_CR31","doi-asserted-by":"publisher","first-page":"e30745","DOI":"10.1371\/journal.pone.0030745","volume":"7","author":"J Wills","year":"2012","unstructured":"Wills J, Credle J, Oaks AW et al (2012) Paraquat, but not Maneb, induces Synucleinopathy and Tauopathy in Striata of mice through inhibition of Proteasomal and autophagic pathways. PLoS ONE 7:e30745. https:\/\/doi.org\/10.1371\/journal.pone.0030745","journal-title":"PLoS ONE"},{"key":"4130_CR32","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1089\/ars.2009.2459","volume":"11","author":"AC Crist\u00f3v\u00e3o","year":"2009","unstructured":"Crist\u00f3v\u00e3o AC, Choi DH, Baltazar G et al (2009) The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal 11:2105\u20132118. https:\/\/doi.org\/10.1089\/ars.2009.2459","journal-title":"Antioxid Redox Signal"},{"key":"4130_CR33","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1128\/MCB.26.6.2160-2174.2006","volume":"26","author":"T Ueyama","year":"2006","unstructured":"Ueyama T, Geiszt M, Leto TL (2006) Involvement of Rac1 in activation of Multicomponent NOX1- and NOX3-Based NADPH oxidases. Mol Cell Biol 26:2160. https:\/\/doi.org\/10.1128\/MCB.26.6.2160-2174.2006","journal-title":"Mol Cell Biol"},{"key":"4130_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/J.BBRC.2013.06.085","volume":"437","author":"AC Crist\u00f3v\u00e3o","year":"2013","unstructured":"Crist\u00f3v\u00e3o AC, Barata J, Je G, Kim YS (2013) PKC\u03b4 mediates paraquat-induced NOX1 expression in dopaminergic neurons. Biochem Biophys Res Commun 437:380. https:\/\/doi.org\/10.1016\/J.BBRC.2013.06.085","journal-title":"Biochem Biophys Res Commun"},{"key":"4130_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.TOX.2017.02.009","volume":"380","author":"L Hou","year":"2017","unstructured":"Hou L, Zhang C, Wang K et al (2017) Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation. Toxicology 380:1\u201310. https:\/\/doi.org\/10.1016\/J.TOX.2017.02.009","journal-title":"Toxicology"},{"key":"4130_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/J.NEUROSCIENCE.2019.09.006","volume":"419","author":"L Hou","year":"2019","unstructured":"Hou L, Sun F, Sun W et al (2019) Lesion of the Locus Coeruleus damages Learning and Memory Performance in Paraquat and Maneb-induced mouse Parkinson\u2019s Disease Model. Neuroscience 419:129\u2013140. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2019.09.006","journal-title":"Neuroscience"},{"key":"4130_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/J.NEURO.2021.01.002","volume":"83","author":"K Wang","year":"2021","unstructured":"Wang K, Shi Y, Liu W et al (2021) Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson\u2019s disease model through inhibition of microglial activation. Neurotoxicology 83:129\u2013136. https:\/\/doi.org\/10.1016\/J.NEURO.2021.01.002","journal-title":"Neurotoxicology"},{"key":"4130_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000501339","volume":"26","author":"J Wang","year":"2019","unstructured":"Wang J, Wang W, Zhai H (2019) MicroRNA-124 enhances dopamine receptor expression and neuronal proliferation in mouse models of Parkinson\u2019s Disease via the hedgehog signaling pathway by targeting EDN2. Neuroimmunomodulation 26:174\u2013187. https:\/\/doi.org\/10.1159\/000501339","journal-title":"Neuroimmunomodulation"},{"key":"4130_CR39","doi-asserted-by":"publisher","first-page":"104588","DOI":"10.1016\/J.ARCHGER.2021.104588","volume":"99","author":"F Zhang","year":"2022","unstructured":"Zhang F, Yao Y, Miao N et al (2022) Neuroprotective effects of microRNA 124 in Parkinson\u2019s disease mice. Arch Gerontol Geriatr 99:104588. https:\/\/doi.org\/10.1016\/J.ARCHGER.2021.104588","journal-title":"Arch Gerontol Geriatr"},{"key":"4130_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jconrel.2016.06.005","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Paiva J, Santos T et al (2016) MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson\u2019s disease. J Control Release 235:291\u2013305. https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.005","journal-title":"J Control Release"},{"key":"4130_CR41","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.ymthe.2022.06.003","volume":"30","author":"M Esteves","year":"2022","unstructured":"Esteves M, Abreu R, Fernandes H et al (2022) MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson\u2019s disease. Mol Ther 30:3176\u20133192. https:\/\/doi.org\/10.1016\/j.ymthe.2022.06.003","journal-title":"Mol Ther"},{"key":"4130_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04319-x","volume":"1211 12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen X, Wang Y et al (2021) The essential role of transcription factor PITX3 in preventing mesodiencephalic dopaminergic neurodegeneration and maintaining neuronal subtype identities during aging. Cell Death Dis 2021 1211 12:1\u201311. https:\/\/doi.org\/10.1038\/s41419-021-04319-x","journal-title":"Cell Death Dis 2021"},{"doi-asserted-by":"publisher","unstructured":"Chen J, Kang X, yu, Tang C xi, Gao Dshuai (2017) Impact of PITX3 gene knockdown on glial cell line-derived neurotrophic factor transcriptional activity in dopaminergic neurons. Neural Regen Res 12:1347\u20131351. https:\/\/doi.org\/10.4103\/1673-5374.213557","key":"4130_CR43","DOI":"10.4103\/1673-5374.213557"},{"key":"4130_CR44","doi-asserted-by":"publisher","first-page":"e1409","DOI":"10.1002\/WRNA.1409","volume":"8","author":"P Pereira","year":"2017","unstructured":"Pereira P, Queiroz JA, Figueiras A, Sousa F (2017) Current progress on microRNAs-based therapeutics in neurodegenerative diseases. Wiley Interdiscip Rev RNA 8:e1409. https:\/\/doi.org\/10.1002\/WRNA.1409","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"4130_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/J.EXPNEUROL.2008.11.003","volume":"215","author":"K Prasad","year":"2009","unstructured":"Prasad K, Tarasewicz E, Mathew J et al (2009) Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain. Exp Neurol 215:358. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2008.11.003","journal-title":"Exp Neurol"},{"key":"4130_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-58599-y","volume":"101 10","author":"L Gao","year":"2020","unstructured":"Gao L, Yuan H, Xu E, Liu J (2020) Toxicology of paraquat and pharmacology of the protective effect of 5-hydroxy-1-methylhydantoin on lung injury caused by paraquat based on metabolomics. Sci Rep 2020 101 10:1\u201316. https:\/\/doi.org\/10.1038\/s41598-020-58599-y","journal-title":"Sci Rep 2020"},{"key":"4130_CR47","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","volume":"39","author":"NP Visanji","year":"2016","unstructured":"Visanji NP, Brotchie JM, Kalia LV et al (2016) \u03b1-Synuclein-based animal models of Parkinson\u2019s Disease: challenges and opportunities in a new era. Trends Neurosci 39:750\u2013762. https:\/\/doi.org\/10.1016\/j.tins.2016.09.003","journal-title":"Trends Neurosci"},{"key":"4130_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-017-0416-x","volume":"5","author":"CW Ip","year":"2017","unstructured":"Ip CW, Klaus L-C, Karikari AA et al (2017) AAV1\/2-induced overexpression of A53T-\u03b1-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson\u2019s disease. Acta Neuropathol Commun 5:11. https:\/\/doi.org\/10.1186\/s40478-017-0416-x","journal-title":"Acta Neuropathol Commun"},{"key":"4130_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-8-44","volume":"8","author":"M Oliveras-Salv\u00e1","year":"2013","unstructured":"Oliveras-Salv\u00e1 M, Van der Perren A, Casadei N et al (2013) rAAV2\/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Mol Neurodegener 8:44. https:\/\/doi.org\/10.1186\/1750-1326-8-44","journal-title":"Mol Neurodegener"},{"key":"4130_CR50","first-page":"147","volume":"70","author":"Y Chen","year":"2015","unstructured":"Chen Y, Zhao H, Tan Z et al (2015) Bottleneck limitations for microRNA-based therapeutics from bench to the bedside. Pharmazie 70:147\u2013154. https:\/\/doi.org\/91\/ph.2015.4774","journal-title":"Pharmazie"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04130-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:19:13Z","timestamp":1717233553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04130-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["4130"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04130-y","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"type":"print","value":"0364-3190"},{"type":"electronic","value":"1573-6903"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving animals were approved by the Directorate-General for Food and Veterinary (DGAV), the Portuguese National Authority for Animal Health (21\/01\/2019; reference number 0421\/000\/000\/2019) and were in accordance with the Directive 2010\/63\/EU of the European Parliament and the Council on the protection of animals used for scientific purposes. This study did not include human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable. This study did not include human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable. This study did not include human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}